Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.29
-0.16 (-2.48%)
At close: Aug 1, 2025, 4:00 PM
6.35
+0.06 (0.95%)
After-hours: Aug 1, 2025, 6:28 PM EDT
Paycor HCM Market Cap
Candel Therapeutics has a market cap or net worth of $335.41 million as of August 1, 2025. Its market cap has increased by 54.62% in one year.
Market Cap
335.41M
Enterprise Value
254.16M
1-Year Change
54.62%
Ranking
Category
Stock Price
$6.29
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $335.41M, an increase of 50.82%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 343.67M | -6.78% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |